# Photoactivated disinfection procedure for denture stomatitis in diabetic rats

**Authors:** Xiao Zhang, Zirui Zhao, Ruiqi Zhang, Juan Liu, Zhijiao Guo, Qiaoyu Hu, Na Liu, Qing Liu

PMC · DOI: 10.7717/peerj.17268 · 2024-04-30

## TL;DR

This study tested a light-based treatment for denture stomatitis in diabetic rats and found it effective in reducing fungal infections and inflammation.

## Contribution

The study introduces a photoactivated disinfection method for treating denture stomatitis in a diabetic rat model.

## Key findings

- PAD reduced fungal load and inflammation markers in diabetic rats with denture stomatitis.
- Multiple PAD treatments were more effective than a single treatment and comparable to nystatin.
- The infection group showed higher fungal and inflammatory levels compared to treated groups.

## Abstract

To study the efficacy of PADTM Plus-based photoactivated disinfection (PAD) for treating denture stomatitis (DS) in diabetic rats by establishing a diabetic rat DS model.

The diabetic rat DS model was developed by randomly selecting 2-month-old male Sprague-Dawley rats and dividing them into four groups. The palate and denture surfaces of rats in the PAD groups were incubated with 1 mg/mL toluidine blue O for 1 min each, followed by a 1-min exposure to 750-mW light-emitting diode light. The PAD-1 group received one radiation treatment, and the PAD-2 group received three radiation treatments over 5 days with a 1-day interval. The nystatin (NYS) group received treatment for 5 days with a suspension of NYS of 100,000 IU. The infection group did not receive any treatment. In each group, assessments included an inflammation score of the palate, tests for fungal load, histological evaluation, and immunohistochemical detection of interleukin-17 (IL-17) and tumor necrosis factor (TNF-α) conducted 1 and 7 days following the conclusion of treatment.

One day after treatment, the fungal load on the palate and dentures, as well as the mean optical density values of IL-17 and TNF-α, were found to be greater in the infection group than in the other three treatment groups (P < 0.05). On the 7th day after treatment, these values were significantly higher in the infection group than in the PAD-2 and NYS groups (P < 0.05). Importantly, there were no differences between the infection and PAD-1 groups nor between the PAD-2 and NYS groups (P > 0.05).

PAD effectively reduced the fungal load and the expressions of IL-17 and TNF-α in the palate and denture of diabetic DS rats. The efficacy of multiple-light treatments was superior to that of single-light treatments and similar to that of NYS.

## Linked entities

- **Chemicals:** toluidine blue O (PubChem CID 7083), nystatin (PubChem CID 4568)
- **Diseases:** denture stomatitis (MONDO:0006723), diabetes (MONDO:0005015)

## Full-text entities

- **Genes:** Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Il17a (interleukin 17A) [NCBI Gene 301289] {aka CTLA-8, IL-17, IL-17A, Il17}, tumor necrosis factor [NCBI Gene 103694380]
- **Diseases:** DS (MESH:D013282), inflammation (MESH:D007249), infection (MESH:D007239), fungal (MESH:D009181), PAD-2 (MESH:D020803), diabetic (MESH:D003920)
- **Chemicals:** NYS (MESH:D009761), toluidine blue O (MESH:D014048), PADTM Plus (-)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Figures

14 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11067891/full.md

---
Source: https://tomesphere.com/paper/PMC11067891